Form 4: NeuroPace CEO Joel Becker Reports Acquisition of Stock Options and Restricted Stock Units
SEC Form 4 Filing
NeuroPace's CEO, Joel Becker, reports the acquisition of stock options and restricted stock units (RSUs) in the company.
Summary
- On February 27, 2024, Joel Becker, the CEO of NeuroPace Inc, reported acquiring 52,470 restricted stock units (RSUs) and 104,720 stock options.
- The RSUs vest 25% on February 27, 2025, and the remaining RSUs vest in twelve equal quarterly installments thereafter.
- The stock options have an exercise price of $17.11 and vest 25% on February 27, 2025, with the remaining shares vesting in 36 equal monthly installments.
- Following these transactions, Becker directly owns 52,470 shares of common stock represented by RSUs and holds options for 104,720 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options and RSUs is a standard practice and signals confidence from the company in its leadership. The vesting schedule promotes long-term commitment.
Positives
- The granting of RSUs and stock options to the CEO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.
- The vesting schedules for both the RSUs and stock options encourage long-term commitment from the CEO.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CEO's continued investment in the company's future.
Stakeholder Impact
- The acquisition of stock options and RSUs by the CEO aligns his interests with those of the shareholders, potentially leading to increased shareholder value.
- Employees may view this as a positive sign, indicating the company's confidence in its leadership and future prospects.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of transaction: Acquisition of RSUs and stock options. |
| 02/27/2025 | 25% of RSUs and stock options vest. |
| 02/26/2034 | Expiration date of the stock options. |
| 02/28/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.